PARSIPPANY, N.J. – March 21, 2025 – Today, Zoetis announced the Vanguard® B Intranasal vaccine is now available in a 0.5 mL dose for protection against Bordetella bronchiseptica, also known as kennel cough. Approved by the USDA on August 31, 2024, the new formulation is a smaller dose size and single nostril administration to ensure a more comfortable and convenient experience for puppies as young as three weeks old.
“Protecting our pets’ health starts with preventative care, and vaccination is an effective way to safeguard your dog from a preventable illness like kennel cough,” said Tara Bidgood, DVM, PhD, DACVCP, Vice President, Head of Veterinary Professional Services and Medical Affairs, Independent Petcare at Zoetis. “We are pleased to offer this new formulation of our trusted Vanguard® B Intranasal vaccine to provide early protection for dogs as young as three weeks old. Zoetis remains committed to advancing animal health through innovation, and the availability of the smaller 0.5 mL dose vaccine reflects our dedication to providing early, effective, science-backed solutions that benefit both pets and their owners.”
Kennel cough is a highly contagious respiratory disease that spreads year-round, particularly in environments where dogs are in close contact with one another. Dogs of all ages – especially those who frequent parks, go to the groomer, or stay at boarding facilities – are at risk of contracting kennel cough. Common signs and symptoms include a frequent, honking cough, sneezing, irritated eyes, and a runny nose. Most dogs infected with kennel cough are contagious before they start showing symptoms, leading to outbreaks as the disease spreads quickly.[i]
About Vanguard® B Intranasal
Vanguard® B Intranasal is veterinarians’ #1 monovalent intranasal Bordetella vaccine choice designed to protect healthy dogs as young as three weeks old against Bordetella bronchiseptica, commonly known as kennel cough. This updated 0.5 mL dose and single-nostril administration, provides the same robust protection as the previously approved 1 mL dose with a smaller volume for easier administration.
To learn more about how you can protect your dog with Vanguard B Intranasal 0.5 mL, visit ZoetisPetcare.com/Vanguard-Dog/ and talk to your veterinarian about this new, lower-volume option.
About Bordetella bronchiseptica
Bordetella bronchiseptica is a highly contagious respiratory disease in dogs that spreads year-round, particularly in environments where dogs are in close contact or through shared water bowls or toys. Symptoms can include a runny nose, sneezing, chest inflammation and a resulting loud, deep cough. In severe cases, Bordetella can lead to pneumonia, hospitalization and sometimes death in dogs at risk.
The American Animal Hospital Association (AAHA) recommends annual intranasal vaccination for optimal protection against Bordetella bronchiseptica.[ii] Keeping your dog’s vaccination status current helps to reduce the chance of your dog becoming ill and lower the risk of your dog developing severe disease or spreading infection to other dogs.[iii]
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis, generated revenue of $8.5 billion in 2023 with approximately 14,100 employees. For more information, visit www.zoetis.com.
###
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. @2025 Zoetis Services LLC. All rights reserved. SAB-01159
[i] Kennel Cough Fact Sheet. American Humane. (n.d.). Accessed December 23, 2024. https://www.americanhumane.org/fact-sheet/kennel-cough/
[ii] 2022 AAHA Canine Vaccination Guidelines: Guideline at-a-Glance. www.aaha.org. Published 2022. Accessed May 02, 2024. https://www.aaha.org/resources/2022-aaha-canine-vaccination-guidelines/
[iii] Canine infectious respiratory disease complex (Kennel cough). American Veterinary Medical Association. (n.d.). Accessed December 23, 2024. https://www.avma.org/resources-tools/pet-owners/petcare/canine-infectious-respiratory-disease-complex-kennel-cough
